| Date Filed | Type | Description |
| 08/17/2023 |
4
| dEsparbes Eric (CFO) has filed a Form 4 on BIORA THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 40,022 shares
@ $3.14, valued at
$125.7k
Granted 219,650 shares
@ $0 |
|
| 05/17/2023 |
4
| dEsparbes Eric (CFO) has filed a Form 4 on BIORA THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 2,807 shares
@ $3.35, valued at
$9.4k
|
|
| 03/17/2023 |
4
| dEsparbes Eric (CFO) has filed a Form 4 on BIORA THERAPEUTICS, INC.|
Txns:
| Granted 62,225 shares
@ $0
Granted 22,692 shares
@ $0
Paid exercise price by delivering 11,216 shares
@ $2.56, valued at
$28.7k
|
|
| 01/05/2023 |
4
| dEsparbes Eric (CFO) has filed a Form 4 on BIORA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 95 shares
@ $0 |
|
| 11/16/2022 |
4
| dEsparbes Eric (CFO) has filed a Form 4 on BIORA THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 5,194 shares
@ $0.27, valued at
$1.4k
|
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2022 |
4
| dEsparbes Eric (CFO) has filed a Form 4 on PROGENITY, INC.|
Txns:
| Granted 231,693 shares
@ $0
Granted 375,032 options to buy
@ $1, valued at
$375k
|
|
| 02/17/2022 |
4
| dEsparbes Eric (CFO) has filed a Form 4 on PROGENITY, INC.|
Txns:
| Paid exercise price by delivering 4,919 shares
@ $1.9, valued at
$9.3k
|
|
| 08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| dEsparbes Eric (CFO) has filed a Form 4 on PROGENITY, INC.|
Txns:
| Granted 67,953 options to buy
@ $4.73, valued at
$321.4k
|
|
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| dEsparbes Eric (CFO) has filed a Form 4 on PROGENITY, INC.|
Txns:
| Paid exercise price by delivering 1,228 shares
@ $6.32, valued at
$7.8k
|
|
| 08/18/2020 |
4
| dEsparbes Eric (CFO) has filed a Form 4 on PROGENITY, INC.|
Txns:
| Granted 36,243 shares
@ $0
Granted 73,863 options to buy
@ $7.71, valued at
$569.5k
Granted 28,406 options to buy
@ $9.88, valued at
$280.7k
|
|
| 06/18/2020 |
3
| dEsparbes Eric (CFO) has filed a Form 3 on PROGENITY, INC. |
| 05/22/2018 |
4
| dEsparbes Eric (SVP and CFO) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Paid exercise price by delivering 7,901 shares
@ $14.59, valued at
$115.3k
Sold 5,808 shares
@ $14.3979, valued at
$83.6k
|
|
| 03/06/2018 |
4
| dEsparbes Eric (Interim PEO, SVP and CFO) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Granted 93,056 shares
@ $0 |
|
| 02/22/2018 |
4
| dEsparbes Eric (Interim PEO, SVP and CFO) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Paid exercise price by delivering 24,876 shares
@ $16.44, valued at
$409k
Sold 5,378 shares
@ $16.5164, valued at
$88.8k
|
|
| 11/22/2017 |
4
| dEsparbes Eric (SVP and CFO) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Paid exercise price by delivering 6,141 shares
@ $13.17, valued at
$80.9k
Sold 1,825 shares
@ $13.04, valued at
$23.8k
Sold 13,460 shares
@ $13.3114, valued at
$179.2k
|
|
| 08/22/2017 |
4
| dEsparbes Eric (SVP and CFO) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Paid exercise price by delivering 5,770 shares
@ $12.28, valued at
$70.9k
Sold 1,825 shares
@ $12.2, valued at
$22.3k
|
|
| 05/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/23/2016 |
4
| dEsparbes Eric (SVP and CFO) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Paid exercise price by delivering 2,845 shares
@ $11.79, valued at
$33.5k
Sold 3,700 shares
@ $11.77, valued at
$43.5k
|
|
| 05/20/2016 |
4
| dEsparbes Eric (SVP and CFO) has filed a Form 4 on Innoviva, Inc.|
Txns:
| Paid exercise price by delivering 2,818 shares
@ $11.09, valued at
$31.3k
|
|